SGP

SpyGlass Pharma, Inc.

Healthcare · Biotechnology

$205.22 sample

+0.32 (+0.16%) 1D

Market cap

$736.2B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-28

Alerts

8

Price$205.22 +11.80% 3M daily closessample

211.28178.56

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28SECDEF 14A filed
Sep 23SECForm 144 filed
Sep 15INSInsider sell: Chief Financial Officer
Sep 04INSInsider sell: 10% owner
Aug 27INSInsider sell: Chief Financial Officer
Aug 21INSInsider buy: 10% owner
Aug 12SECDEF 14A filed
Aug 04INSInsider buy: Director

Sign up to see the real SGP record →

Company facts

SEC EDGAR registration

Name: SpyGlass Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +30sample, -100 to +100
Reporting currency: USD

Who is positioning in SGP

sample

Insiders: 7 insider transactions over 90 days, net selling, $613.3M
Congress: 5 members traded over 90 days
Institutions · 13F: 26 funds hold $4.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$42.0B +10.4% y/y

Q4 2024Q3 2026

Inventory$26.5B +15.1% y/y

Q4 2024Q3 2026

Accounts receivable$19.7B +16.5% y/y

Q4 2024Q3 2026

Total debt$53.8B +19.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $267.6B -7.8% 3M
Sample peer B: $606.4B +3.3% 3M
Sample peer C: $95.7B +10.3% 3M
Sample peer D: $163.1B +8.1% 3M
Sample peer E: $711.8B +10.4% 3M